Ariful Haque Abir

Berlin, Germany.

About

A Senior Scientist specializing in immunometabolism, cellular signaling, and functional genomics, with a strong focus on drug discovery and translational research. My work centers on understanding how metabolic pathways shape immune cell function and on identifying and validating novel therapeutic targets for immune-mediated diseases. I have hands-on experience in managing external collaborations and CRO partnerships, ensuring efficient project management.

Work

MetaImmune Therapeutics GmbH

Senior Scientist

Berlin, Berlin, Germany

Jan 2026→ Present

Biotechnology

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)

Postdoctoral Researcher

Germany

May 2025→ Present

Charité - Universitätsmedizin Berlin

Postdoctoral Scientist

Germany

Jan 2025→ Present

Universitätsklinikum Erlangen

Research Scientist (Post-doctoral)

Germany

Jul 2024→ Dec 2024

Friedrich-Alexander-Universität Erlangen-Nürnberg Medizinische Fakultät

Scientist

Germany

Jan 2023→ Jun 2024

Universitätsklinikum Erlangen

Wissenschaftlicher Mitarbeiter

Germany

Jan 2021→ Dec 2022

Education

FAU Erlangen-Nuremberg

Erlangen, Bavaria, Germany

Jan 2021→ May 2024

Magna cum laude Molecular Immunology

North South University

Bangladesh

Jan 2021→ Dec 2022

Master of Pharmacy in Pharmacology & Clinical Pharmacy

North South University

Bangladesh

Jan 2021→ Dec 2022

Bachelor of Pharmacy

Publications

Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction

Life Sciences

journal-article

Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation

Jan 2025

preprint

Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry

Molecular Metabolism

Jan 2024

journal-article

Activation of GPR35 protects against cerebral ischemia by recruiting monocyte-derived macrophages

Scientific Reports

Jan 2020

journal-article

Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson’s disease

Animal Models and Experimental Medicine

Jan 2020

journal-article